Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.
D000818:Animals; D001549:Benzamides / Q000737:chemistry / Q000378:metabolism*; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism; D002186:Cannabinoids / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D002250:Carbon Radioisotopes; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005260:Female; D005462:Fluorine Radioisotopes; D000882:Haplorhini; D007211:Indoles / Q000737:chemistry / Q000378:metabolism*; D008252:Macaca fascicularis; D008253:Macaca mulatta; D008297:Male; D010880:Piperidines / Q000737:chemistry / Q000378:metabolism*; D049268:Positron-Emission Tomography / Q000379:methods*; D043884:Receptor, Cannabinoid, CB1 / Q000819:agonists* / Q000378:metabolism*
D001549:Benzamides; D002186:Cannabinoids; D002250:Carbon Radioisotopes; D005462:Fluorine Radioisotopes; D007211:Indoles; C541260:N-(4-fluorobenzyl)-4-(3-(piperidin-1-yl)indole-1-sulfonyl)benzamide; D010880:Piperidines; D043884:Receptor, Cannabinoid, CB1